P04: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE VERSUS BORTEZOMIB AND DEXAMETHASONE ALONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: OVERALL SURVIVAL RESULTS FROM THE PHASE 3 CASTOR TRIAL

Detalles Bibliográficos
Autores principales: Sonneveld, P, Chanan-Khan, A, Weisel, K, Nooka, AK, Masszi, T, Beksac, M, Spicka, I, Hungria, V, Munder, M, Mateos, MV, Mark, TM, Levin, MD, Ahmadi, T, Qin, X, Garvin Mayo, W, Gai, X, Carey, J, Carson, R, Spencer, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Poster
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012125/
http://dx.doi.org/10.1097/01.HS9.0000829588.31575.a9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012125/
http://dx.doi.org/10.1097/01.HS9.0000829588.31575.a9

Ejemplares similares